As CML cell lines can express varying levels of BCR-ABL and have different processing efficiencies, we included an additional CML cell line, K562, transduced to express HLA-A2 and edited using CRISPR-Cas9. Here, ABL1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.